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INTRODUCTION

After seeing the end stage of several cases of the
disease trachoma I was stimulated to investigate, through
the medium of reading, the cause and treatment of the disease. Because it is the leading cause of blindness in various sections of the world and because the majority of
students may practice medicine in those parts of the country where trachorna is prevalent I feel that any time spent
on the subject is of great value.
I have limited this paper to the etiology of trachoma.
and its treatment with sulfanilamide chiefly because the
literature on all phases of the disease is so voluminous
that to cover it would take more time than ie allotted,
and because I feel that the causative agent and treatment
go hand in hand, therefore, cannot be divorced.
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HISTORICAL BACKGROUND OF THE OCCURRENCE OF TRACHON....A
In the ancient Egyptian manuscript, the Papyrus
Ebers (5), which dates back to the eighteenth dynasty
or to a period of time estimated to be 1553 - 1500

B.c.,

is found the expression 'hetae m mrt'. This has been interpreted as referring to trachoma. So it is seen that
trachoma is one of the oldest diseases known. Even though
there is considerable literature on Egypt little or no
mention of trachoma. is found so it is reasonable to assume
that the disease was not as prevalent or as severe as it
is today or was in the comparatively recent past. In 1481
Rabbi Meshoolam Ibn Menahen referred to trachoma; a century later Prosper Alpinus, a Venetian physician, again
ref erred to the disease and from this time on trachoma. became permanently and commonly implanted in Egypt (24).
It is a well known fact that eye diseases have always
been common in the Orient and trachoma. undoubtedly was present in the ancient Orient. Mijaachita states that in Japan
trachoma. dates back as far as 1200 years ago (46).
Herodatus (482 - 424 B.C.) is thought to have been
the first of the Greeks to ref er to trachoma., the evidence
consisting of his comment concerning the discharge of two
of thirty-two soldiers at Thermopylae because of ophthalmia,
the expression signifying trachoma. Aristophanes (444 - 380
B.C.) discussed in a summary fashion the cure and treatment

of the disease in Plutue and again refers to the affliction in Frogs. Hippocrates (460 - 3?? B.C.) wrote a desscription of ophthalmia and trichiasis, and for treatment
recommended applications of copper acetate and fresh gra.pe
juice. Also Plato, Aristotle, and Plutarch were aware of
the disease (24).
The Aramaics or Syriacs knew of trachoma and pannus
because they designated trachoma as 'garab' and pannus as
'sebel' and recommened scraping and scarification in the
treatment. The book on ophthamology " Tadkirat-el-Kahhalint•
written at Bagdad in the eleventh century by Ali Ibn-elAissa is probably the oldest book on diseases of the eye
that has been preserved in it's original language. In this
book is found an entire chapter on trachoma and the treatment is quite detailed for each of the four stages of the
disease. So this may be judiciously accepted as evidence
of the importance attributed to trachoma by the Arabic
physicians (9).
From the material presented so far it is seen that
trachoma was well-known in the old countriee, however, it
was not until the nineteenth century that Europe became
fully aware of the disease. At this time under the name of
Egyptian ophthalmia it was disseminated at a terrific rate
of speed.
During 1?98 Napoleon and his armies were invading the
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land of Egypt and it is thought that this expedition was
responsible for the spread of trachoma. throughout Europe.
Larrey, Vetch, and Eble, military surgeons of the French,
British, and Prussian armies accurately described the disease and the disability it caused. On the return journey
the soldiers spread the disease en route and carried it into their native lands. The Russian army did not incur the
disease during the Napoleonic wars but it was not long afterwards that it began to appear sporadically in Russia. Consequently trachoma has become firmly implanted in Europe (43).
When the history of trachoma. in the New World is considered nothing definite or tangible can be found. Some
authorities believe that it was imported by the Spanish
conquistadores (75). But other observers maintain that the
Spanish probably contracted the disease from the Indians
and contend that it is of more recent origin (15). Lewis
and Clark comment a little on "sore eyes" among the Choppunieh but it is uncertain as to whether or not they were
describing trachoma. At the Flathead agency in Montana in
1868 McCormick reported "sore eyes" and Fox believes that
the Blackfeet Indians contracted trachoma from the Indians
at the Flathead agency. On inquiry to the Bureau of Indian
Affairs Fox learned that the Indians thought that trachoma
was introduced to them by employees of the Hudson's Bay
Company. However, he presents sufficient evidence to relieve
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this blame and states that the Celtic race was entirely
responsible. By 1910 Hodge and Hrdlicka believed that the
disease was permanently established among the Indians (15).
In view of the facts presented above it appears as
though trachoma in the Indians was of fairly recent origin
and probably was brought to them by the white man. However,
Gifford (24) makes a statement that the disease existed
among the Oma.whawe in 1819 prior to the arrival of white
men. According to J.J. Wall (74) the Canadian Indians believe that trachoma was brought to them from .American tribes
accompanying the early white traders.
Up to 1850 the immigrants coming to this country were
mainly British, Irish, German, and Scandinavian and the
incidence of trachoma. was not so great. But after 1850 the
immigrants consisted of Italians, Austrians, Slave, Russians
and Turks for the most part and the incidence of the disease increased tremendously. Cases and outbreaks of the
disease, especially among school children and the alien
population, were noted by numerous observers, and because
of the contagiousness of the disease and the seriousness
of it's sequelae it was regarded as a menace to the public
health. Consequently in 1897 the Treasury Department, then
in charge of immigration, classified trachoma. as "dangerous
contagion" and so prevented trachoma.tous individuals from
entering this country (42,6).
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In Canada the disease is found also among immigrants
from Eastern and Southeastern Europe, as well as among the
Chinese in British Columbia. An endemic focus exists among
the Daukhobors and the incidence of trachorna. in Manitoba
and Saskatchewan is still a serious problem (74).
In Australia the disease appeared with colonization,
however, it has never been a serious problem and has been
eliminated except for foci in Northwest Queensland, West
New South Wales, and the northern and eastern parts of the
continent (40).
I was unable to find any statistics on the occurrence
of trachorna. in Nebraska. However, as a result of direct communication with several ophthamologists who have worked in
the University of Nebraska Dispensary and outstate men I
learned that although most of them have seen and treated
the disease the incidence has not been high in their experiences.
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THE ETIOLOGY OF TRACHOMA
Since the time trachoma was first described a number
of concepts have been advanced to account for the origin
of the disease. Although most authorities of the present
generation agree that trachoma. is a specific infectious
disease there are still some adherents to the numerous and
varied theories. In the material to follow an attempt to
review these theories will be made. Also the recent experimental work will be reviewed to try and make it possible
to present the present day concept of the origin and the
evolution of the disease.
Various Theories as to the Causative Agent
Some observers have advanced the idea that the lymphatic constitution of an individual may be an important
factor, either predisposing or causative. There are not
many in this country adhering to this idea, in fact, it
is disputed by some whosay that constituents of this theory
are describing folliculosis and not trachoma (24).
Because trachoma. has a high incidence in the lower income group of people, where malnutrition is seen, many authorities (16,58,63) believed that the state of nutrition
played an important part in the development of the disease.
But the occurrence in well-nourished persons such as wrestlers (49) certainly isn't in keeping with this idea.
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Even though this concept was advanced before the specific
knowledge of vitamins came into being (knowing that Vit.
A plays an important part in the development of eye diseases), recent experiments have failed to show that either
a defective diet or depressed physical condition is essential for the development of trachoma (31 1 73,22,55). In fact
it seems as though the anima.ls used in the vitamin deficiency experiments were less reactive and probably a little
more resistant to trachoma than normal animals, that is,
those on an adequate diet.
From time to time numerous observers have attempted
to show that trachoma is a manifestation of various clinical entities, such as tuberculosis and syphilis. According to Pascheff (48) tuberculosis is the underlying and
responsible factor in trachoma.. He believes that the eye
symptoms arise from an endogenous tuberculous source. This
is not such an unreasonable concept since it is a well established fact that both trachoma and tuberculosis have a
high incidence among the poverty-stricken and unsanitary
groups of people. The only support for this idea is the
differential leucocyte estimation and tuberculin skin tests
which run parallel in both diseases. However, experimental
evidence has failed to show any correlation between trachoma.
and tuberculosis (24).
Syphilis is another specific disease that has been
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blamed for the initiation and development of trachoma.
And some observers contend that symptoms of the disease
are done away with under antiluetic treatment. But there
is very little evidence to indicate more than a coincidental relationship, in fact, in the Trachoma. Hospital at
Rolla, Missouri it is found that trachoma. very rarely
occurs in syphilitic patients (24).
Some observers believe that trachoma. is actually a
local manifestation of a generalized disease and not a
local disease per se. In these instances the disease is
thought to be the result of malaria (30), an allergic
phenomenon (35), a plasmoma., endocrine disturbance, a
nasal infection, and capillary changes (24).
From time to time various men (11,12,44) have stated
that they believe trachoma. is transmitted by different insects. Also, Dr. Myles Standish (62) after observing immigrants for a number of years surmised that the acute cases
must have contracted the disease while on board ship and
so he advanced the theory of an intermediate insect host
and named the bed-bug as the insect responsible. Standish
also assumed that the cases of trachoma seen in loggers,
who srent the winter in unsanitary camps, and in the Kentucky mountaineers was propogated through the bed-bug. And
Dr. H.B. Young (77) in a direct rebuttal to Dr. J.M. Patton's
report on the occurrence of trachoma. in professional wrestlers
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states that he believes an investigation of the wrestler's
sleeping quarters for the bed-bug would probably reveal
it's presence. However, I believe that Dr. Patton (49) has
rightly assumed that the transmission of trachoma. in his
series of eight cases in wrestlers was through direct contact rather than through the medium of a bed-bug. Nicolle
and Cuenod succeeded successfully in transmitting trachoma
to monkeys with flies and lice but it is not unreasonable
to assume that objects other than insects can absorb infectious material and so transmit the disease. Thia assumption
is borne out by the fact that the usual method of spread
is by coming into contact with infectious material on a
towel or some other inanimate material used by a trachomatous
individual. Nicolle and Cuenod allowed their insects to
absorb infectious material then dissected their heads and
feet and then inoculated animals. But because their experiments were extremely artificial not much weight is given
to their results (24).
Infectious Nature and Transmissibility of Agent
There is little doubt in the minds of the majority of
observers that trachoma is a cormnunicable disease. Numerous
experiments have been undertaken in which man was inoculated
with trachomatous tissue. Suffice to say that all experiments
from 1816 to 1937 prove that trachoma is transmissible to man,

11

reproduces itself experimentally as characteristically
as when it occurs spontaneously, the duration of incubation following inoculation varies considerably from a
few days to almost a month, and that epithelial cell inclusions occur and can be found when they are looked for.
However, some have stated that the experimental inoculation
of man with trachoma.tous material resulting in a clinically typical disease is not due to infection but a combination of trauma and secondary infection. But there is
sufficient evidence of accidental transmission to man, as
in doctors and nurses, to rule out such concepts (24).
While on this subject one might wonder why the incidence
of trachoma among the ophthamologists and attendants is
not any greater than it is. The obvious conclusion is
that trachoma. although infectious is not so highly contagious.
Experiments (26,27) carried on in the United States
Trachoma. Hospital at Rolla, Missouri have shown that monkeys and apes may be infected with material derived from
patients with trachoma, that human material is not infectious for other animals and is tolerated without visible
effect even by monkeys when introduced into tissues other
than the conjunctiva. The observers (27) also found that
it was not possible to adapt the infection permanently to
monkeys, thus indicating a high degree of tissue specialization by the infectious agent. They also found that
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recovery from the experimental disease affords no measurable protection to subsequent inoculation with infectious
tissues.
Microorganisms Associated with Trachoma. - not Rickettsial
From the material presented so far it seems as though
trachoma. is an infectious disease experimentally transmissible to man, apes, and monkeys. So we find that as far back
as 1881, when the science of bacteriology first came into
being, a search for the specific microorganism was initiated. Since that time different biological agents have been
pointed out as being directly related to trachoma.. Eight
different observers reported the presence of protozoan
forms in trachoma.tous tissues but in only one instance was
transmission attempted and the results indicated that the
organism was without effect. Six different investigators
reported that Blastomyces were seen in sections of trachomatous tissue but only one man succeeded in cultivating the
the organism. Both Cryptococcus and Streptothrix have been
cultivated from trachoma.tous tissue but the evidence that
they are etiologically responsible for trachoma. is sadly
lacking. When it was proven that bacteria cause disease
then many observers sought to demonstrate a bacterial agent
as the exciting cause of trachoma. In 1881 Sattler announced he had found a Gram-positive coccus in both conjunctival
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discharge and follicular material of trachornatous patients.
In 1886 Michel found a diplococcus in the discharge and
follicles of sixty-nine patients but it is very doubtful
that he was dealing with trachoma. In 188? on four different occassions cocci were reported as causative agents. In
1889 a motile coccus was isolated from trachoma patients.
Numerous observers since have cultivated cocci from trachomatous patients. So it is quite obvious that cocci have
been isolated on several occassions but the resultant experimental disease indicates that the conjunctival reaction
was in general mild and corneal involvement was lacking
and so cannot be designated as trachoma.. Probably the most
important observation of this group of investigations was
that by Noguchi. He demonstrated a rod-shaped organism
which he called Bacterium granulosis but neither he nor
several other observers were able to produce orhtodox
trachoma with this organism. On several occassions different
investigators have observed a complete lack of specificity
in the bacteria cultivable from trachoma (24).

The Rickettsial Nature of Trachoma.
With the generalized vagueness and doubt of the various organisms advanced investigations were directed toward
some other kind of infectious agent. So in 1933 Busacca
published the first account in regard to a rickettsial
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organism. In 1934 he published two more papers on the
same subject stating that in scrapings derived from the
cornea during trachoma and stained with Giemsa, could be
seen small red-staining bodies in masses and isolated
pairs and that nondescript granules appeared blue. These
bodies were found between, on, or in epithelial cells, as
well as in follicles and in pannus and he considered these
Rickettsiae because they were never observed in normal
individuals, folliculosis, chronic catarrhal keratoconjunctivi tis and several other non-ocular conditions. In
view of these facts Busacca felt that they were specific
for trachoma and so again in 1937 he reaffirms his belief
in the rickettsial origin of the disease.
In 1935 Cuenod observed in Giemsa-stained preparations
of follicular contents small particles stained pale blue
or violet and aggregated in irregular masses between the
epitheloid and mononuclear cells. He designated them as
"plastilles" but did not classify them. Then in two publications in 1936, one by himself and the other in conjunction with Nataf, he says that the plastilles were actually
rickettsia. Also they described several experiments to
show that the rickettsial structures cause trachoma and
multiply in the human body louse. In 1937 these men repeated their original observation and in addition produced
infection in monkeys and a human after purifying the agent
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by inoculation of guiena pigs intratesticularly. In 1936
Poleff found riekettsia-like corpuscles which he identified as those reported previously by Busacca and Cuenod.
He also reported the successful propogation of the rickettsia-like bodies in tissue cultures and suggested the possibility that these bodies enter into the structure of the
epithelial cell inclusion. I..e,ter in 1936 Poleff describes
the technique of cultivation and considered the rickettsial
forms as a phase of the inclusion bodies (24,1).
As stated previously, Cuenod and Nataf in 1936 and
1937 advanced the hypothesis that the louse may be the
insect vector of trachoma.. They also suggest that the
theory of the rickettsial nature of trachoma was strengthened by the observation that maps showing the geographical
distribution of the disease were superimposable on those
of typhus, a definite rickettsial disease. They also suggest
that the agent is identical with R. rocha lima.e or at least
closely related (1). However, Weigl challenges this hypothesis on the basis that intra-anal inoculation of trachomatous material into normal lice gave negative results and
R. rocha lirnae did not infect lice (1). In 1937 Foley and
Parrot (13) confirmed the presence of rickettsial corpuscles
in trachoma. and identified them with inclusion elementary
bodies. They also considered trachoma as a local infection
with rickettsia. Also in 1937 Derkac suggested the theoritcal possibility of a positive Weil-Felix test in trachoma.
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and tested twenty patient's serum of which only five gave
a positive test and he did not consider his results conclusive (1). In a publication by Postic (53) in 1938 he
considers that there may be a relationship between the
organisms of trachoma and those of typhus fever. He suggests
that there may be several groups of trachoma. rickettsiae
and that each endemic area has a different variety, each
giving a different agglutination titer. He states that he
found a certain histological analogy between typhus exanthematious and trachoma in the formation of small follicular
masses around the blood vessels. He also believes that not
counting possible interference with the result by former
spotted fever, the Weil-Felix reaction is indisputably of
importance in demonstrating the role played in trachoma by
rickettsiae. Poleff (51,52) in two different papers in 1939
was convinced from his experiments with pure cultures of
rickettsias that they are identical with the formations
described by Cuenod and Nataf and were the cause of trachoma.
He is also of the opinion that the rickettsia-like corpuscles described by Busacca and Cuenod, at any rate those
which are not debri, cellular or otherwise, are identical
with the inclusion bodies of Halberstadter and Prowazek at
certain stages of their evolution.
So far, for the most part, the evidence has been in
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favor of the rickettsial theory of trachoma. But in 1938,
Thygeson (68), a most outstanding authority on the problem,
examined trachomatous material from Tunis, Brazil, and the
United States for the rickettsia-like bodies described by
Busacca, Cuenod and Nataf. He found that no minute parasitic
bodies other than the elementary and initial bodies of the
epithelial cell inclusion of trachoma could be demonstrated.
So Thygeson contends that the formations which these observers described as occurring in large numbers in the trachoma
follicles are not parasitic but in all probability cell
granules and cytoplasmic aebri. Grttter, in a 1938 publication
considers the rickettsiae of trachoma to be inflamatory
proliferations and divisions of granules which occur normally in epithelial cells (24). In May, 1939 Braley (3)
published a report and reached the conclusion that the
bodies described and photographed by Busacca, Cuenod and
Nataf, and others undoubtedly represent stained mitochondria
and keratin granules rather than rickettsia. In October,
1939 de R8tth (57) was unsuccessful in repeating the experiments of Cuenod and Nataf and states that the appearance
of the follicles does not prove the transmission of trachoma.
and so reaches the same conclusions as did Thygeson. In
July, 1940 Bengtson (1) proposed that the question of the
rickettsial nature of trachoma was a question of "what are
rickettsiae?" She concludes that if the criteria is small,
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bacillary bodies requiring Giemsa stain for demonstration,
intracellular habitat, an arthropod host, and failure to
grow on artificial media, it is questionable whether the
organism of trachoma. could be classified as rickettsial.
She suggests that perhaps the definition of rickettsiae
should be broadened to exclude the arthropod host. However,
she believes that the louse might be an accessory factor.
S.R. Gifford (l?) in a review of the recent advances in
ophthamology contends that Busacca, Cuenod and Nataf have
inconclusive evidence for the rickettsial origin of trachoma.
From the material presented above one can rightly
assume that there has been considerable work done in an
attempt to prove and disprove the rickettsial theory of
etiology. In my opinion the balance of evidence is against
the rickettsial theory. However, the opinions of Cuenod,
Nataf and others have
raised a number of questions which
?
are of certain

p~tical

importance, such as the theory of

louse transmission and the Weil-Felix reaction as a diagnosis
of trachoma and cannot be entirely disregarded. Perhaps in
the near future these questions will be answered.
The Inclusion Body
The research done in this field dates back to 190?
when Halberstadter and Prowazek started investigating trachoma while they were on an expedition to Java to study
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syphilis. Afte inoculating baboons with secretions from
trachomatous patients they examined Giemsa-stained preparations of scrapings from their conjunctiva and discovered within the epithelial cells collections of granules
that have since been known as inclusion bodies, epithelial
cell inclusions, trachoma bodies, Halberstadter and Prowazek bodies, and Prowazek bodies. Because they saw similar
structures in preparations of material taken from trachomatoue patients they concluded this inclusion body was
the infectious agent of trachoma.. Even at this early date
these two men put the infectious agent in the same class
as smallpox, rabies, and molluscum contagiosum, diseases
that are now considered as virus diseases. They also stated
that the conjunctival epithelium is the portal of entry
and chief source of dissemination of the incitant. At the
same time Halberstadter and Prowazek's work was published
Greeff described granules which he considered as the incitant of trachoma.. His descriptions of them coincide perfectly with the elementary granules of the inclusion body.
Later, however, he said that they played no part in the
causation of trachoma. In 1908 Stargardt published a report
on the inclusion bodies but he felt that other agents were
able to stimulate epithelial cell inclusions and a year
later Schmeichler confirmed this idea. Heymann observed
inclusion bodies in ten of fourteen cases of gonorrheal
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blenorrhea thereby seriously conflicting with the conclusions of Halberstadter and Prowazek (24). So whether
the inclusion body was a reaction product of the epithelial
cell in response to gonococcal infection or to the incitant
of trachoma became a serious problem.
In 1910 Herzog considered trachoma the result of gonococcal infection occurring under special conditions. Then
Halberstadter and Prowazek tried to answer the perplexing
problem so they looked for inclusion bodies in genitourinary infections in men and women and were unsuccessful.
And in three infants with gonococcus-free blenorrhea they
saw many inclusions so they concluded that these inclusion
bodies were independent of gonococcal infection. However,
Jancke found inclusion bodies in urethral preparations of
fifteen of sixteen patients with gonococcal infection. Then
Lindner showed that the inclusion bodies were found in all
cases of blenorrhea free of gonococcus so he said that there
are two blenorrheal diseases, inclusion blenorrhea and gonococcal blenorrhea. He stated that the inclusion of blenorrhea
was indistinguishable from that of trachoma.. Halberstadter
and Prowazek actually demonstrated cell inclusions in the
genital epithelium of a mother giving birth to an infant
with inclusion blenorrhea. They felt the inclusion was
similar to but not identical with that of trachoma. and designated it as Chlamydozoon blenorrheae. Later Lindner found
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inclusions and free initial bodies in three instances of
non-gonorrheal urethritis of man so he advanced the idea
that trachoma and inclusion blenorrhea are manifestations
of the same agent and in 1935 he classified them as trachoma
and paratrachoma. Heymann considered the inclusion body
as an unknown independent coexistent virus capable of multiplication and transmission to monkeys and apes. Lindner
and Wolfrum felt that genuine trachoma followed inoculation
of material from inclusion blenorrhea in man. But Gebb and
Lehlein did not think it was trachoma. (24). In 1934 Thygeson
(65) demonstrated inclusion blenorrhea in aduljs was not
trachoma but swimming-bath conjunctivitis. sit£e then this
work has been confirmed by Julianelle (24).
So the work done in this field indicates that in epithelial cells during trachoma there occurs a formation designated as inclusion body which certain authors regard as
the infectious agent. Also inclusion bodies may be found
in other follicular diseases such as inclusion blenorrhea
and swimming-bath conjunctivitis. The occurrence of the inclusion body in experimentally infected humans has been
accepted by Leber, Prowazek, and Thygeson (6?) as proof of
its viability. Still others (45,50) say that the inclusion
body has no relation to trachoma.. Szily, Stanculeanu and
Mihail, Solovief, and the Duke-Elders (10) believe that
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the inclusion body is the result of cytological degeneration. Herzog, Williams, and Bengtson (2) advanced the
idea that the inclusion body was phagocytosed material.
In conclusion, it must be admitted that whatever its
ultimate nature may be the inclusion body constitutes an
integral part of trachoma, and, from the microscopical
point of view it is still the only tangible evidence characteristic of the entire disease. In a later section the relation of the inclusion body, rickettsia, and virus will
be discussed.
The Virus Theory
As far back as 1905, antedating the discovery of the
inclusion body by two years, Pfeiffer and Kuhnt reported
on the infectivity of filtrates of human trachomatous material obtained by filtration through Berkefeld candles.
They found the filtrates were not infectious and so concluded that the infectious agent was not filterable and so
the viral concept indirectly came into being. In 1906
Baiardi, using Berkefeld filters, carried on similar experiments and reached the same conclusion. Hess and

R~mer

using

Berkefeld filters, also came to the same conclusion. In
1907, Fermis and Repetto in a series of four trials in filtration, only one of wl-ich used proper controls, also came
to the same conclusion. In 1908, Bertarelli and Cecchetto
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produced what they considered typical symptoms of experimental trachoma by filtrates. Nicolle, Cuenod and Blaizot
in 1911 and 1912 reported that the agent of trachoma was
a filterable virus. Then because everyone was concerned
with the inclusion body and the advent of the first World
War filtration experiments were forgotten until 1930. At
ihis time Trapesontzewa concluded that the infectious agent
of trachoma was not filterable (24). In 1931 Olitsky, Knutti,
and Tyler (47) in a series of six filtration experiments
had one successful inoculation thereby suggesting that the
process of filtration may be irregular. In 1932 Cattaneo
after carrying out four experiments on filtration concluded

that lack of infectivity of filtrates may have been due to
a loss of virulence during filtration rather than to an inability of the agent to permeate filters. In 1933 Lumbroso
and Thygeson in a series of six experiments did not get any
positive inoculations with their filtrates. In 1933 and 1935
Julianelle and Harrison in a series of eleven experiments on
filtration obtained only one positive result (26,28).
In 1935 Thygeson and Proctor (?O) conducted experiments
in which four inoculations of baboons with bacteria-free
filtrates of trachoma.tous materials resulted in a disease
identical with that produced with unfiltered material and
concluded that these results support the conclusions of
Nicolle, Cuenod and Blaizot that trachoma. is a filterable virus,
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Also in 1935 Julianelle and Harrison (28) in a series of
twelve experiments concluded that filtration of the infectious agent is extremely irregular and that such irregularities may be due to variations in the tissues as well
as to the variations in the composition of the filters.
Again in September, 1935 Thygeson, Proctor, and Richards
(71) using a colloidion membrane, and thereby eliminating
absorption of the agent as occurred in the filtration experiments using Berkefeld filters, confirmed the virus
nature of the etiologic agent of trachoma. In the same
month and year Thygeson (66) states that the evidence obtained from three different methods of attack on the problem of the etiology of trachoma. indicates that trachoma. is
definitely a virus disease. The three methods of attack that
he mentions are:1- Evidence obtained through a process of elimination--Julianelle and Harrison, Stewart, and Thygeson carried
out extensive experiments using pure cultures or cultures
of bacteria pooled in the proportions found on the trachomatous conjunctiva without results.
2- Evidence obtained by filtration experiments
As previously mentioned above conclusive experiments have
shown that the agent is filterable under certain conditions.
3- Evidence obtained by inoculation with bacteria-free trachomatous material ---Julianelle and Harrison using the method of testicular
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inoculation which Noguchi developed to rid vaccine
virus of contaminating bacteria were able to obtain
active bacteria-free trachomatous material capable of
inducing infections in monkeys.
I believe that Thygeson is correct in assuming that the infectious agent is of a virus nature on the basis of this
evidence. In October, 1938 Thygeson and Richards (72) after
a series of studies on the etiology of trachoma. came to the
conclusions that the causative agent is filterable under certain conditions, that it has the characteristics ofa virus
(filterability, inclusion body formation, non-cultivability
on non-living media), that it is identical with the elementary body of Halberstadter and Prowazek. They also believe,
in this paper, that the virus of trachoma., with the viruses
of inclusion blenorrhea and psittacosis, form a group transitional between Rickettsia and the typical viruses.
In my opinion the balance of evidence presented thus
far indicates that the infectious agent of trachoma is of
a virus nature but the definite category has not been adequately decided. In the next section the relation between
the inclusion body and the virus nature will be pointed out
and discussed because I believe that there is a definite
relationship between the two.
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Relationship of the Inclusion Body and the Virus Nature
In 1934 Thygeson (64) reached the conclusion that the
inclusion bodies of Halberstadter and Prowazek constitute
intracellular colonies of the virus in various stages of
development. He believed the small inclusions, made up of
initial bodies, was the early phase of the virus while the
large inclusion, ma.de up of elementary bodies, is the late
phase. In 1935 Thygeson (71) in an experiment, using the
colloidion membrane for filtration, confirmed the virus
nature of the etiologic agent of trachoma., and offers evidence to support the view that the trachoma virus and the
trachoma. elementary body (Halberstadter and Prowazek) are
identical. Again in 1938 Thygeson and Richards (72) state
that they believe the elementary body of trachorra represents
the morphologic unit of the virus of trachoma. because of
the following findings:1- The identity in morphologic structure and staining reactions of the bodies of trachoma. with the similar bodies
of inclusion blenorrhea and psittacosis, established
virus diseases.
2- The presence of the elementary bodies in an infective
filtrate.
3- The presence of the elementary body in the lesions of
trachoma with sufficient constancy to indicate etiologic
significance,

2?

4- Their multiplication in new hosts (man and baboons)
when transferred directly or after filtration.
5- Their persistance in the lesions of trachorna. through
out the period of activity of the disease.
In January, 1941 Julianelle (25) published a paper in which
is suggested an actual relation of the inclusion body to
infectivity to the extent that the inclusion represents an
agglomeration of virus particles. However, he feels that
this opinion requires further study before it can be fully
accepted.
In conclusion of this section I believe that the
opinion stated by Julianelle substantiates the ideas of
other observers but as is stated there will have to be
further collaberation before anything definite can be
decided.
Conclusions
In the final analysis of the question of the etiology
of trachoma I am of the opinion that the major portion of
evidence originating from different laboratories designates
a virus as it's causative agent. Among the chief characteristics indicative of viral activity is the cytoplasmic inclusion body identified with the epithelial cells of the
conjunctiva and, occassionally even of the cornea. While
opinion varies as to it's true significance, the majority
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of observers, begining with Halberstadter and Prowazek,
regard the inclusion body as actually the incitant itself
or as a mass or colony of infectious units and more recently
as agglomerations of virus particles. However, the evidence
brought forward during all these years in support of these
beliefs is essentially morphological, and as such it is
subject to indiviuual interpretation.
The successful treatment of trachoma, as shown in the
next section, with sulfanilamide and the inability to curtail various other virus diseases with the same drug might
be considered by some as concrete evidence that trachoma is
not of the virus class. But since modern research has not
yet determined the definite nature of viruses, one might
speculate that the agent of trachoma is a part of the life
cycle of the virus which can be affected by chemotherapy, in
this instance sulfanilamide, or that there are various species
of viruses that will respond tb chemotherapeutic agents.
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THE TP.EATMENT OF TRACHOMA WITH SUIJ'ANIL.AM:IDE
Introduction
Until very recently the management of trachoma has
been largely a surgical problem. In the history of this
very interesting disease there has been only one procedure which has consistently persisted in spite of the various and numerous procedures advanced, The local application of escharotic drugs, especially some form of copper,
has been used for at least three thousand years. With the
advent of chemotherapy approximately three years ago a
revolution in the management of trachoma has occurred,
chiefly because it is so easy to use, much less painful
to the patient than the old procedures, and good results
are secured by its use.
In this section of my paper I propose to review the
pertinent experimental work, which has been done during
the last three years, in regard to the use of sulfanilamide
and it's derivatives in the treatment of trachoma and subsequently evaluate the publications that have been published up to this time.
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Review of Experimental Work
The first report on the use of sulfanilamide compounds in the treatment of trachoma was published in
August, 1937 by Heinemann (19). Although his series consisted of only three cases his results were so startling
both to himself and the rest of the world that irmnediately
other observers sought to determine the value of this
miracle drug. And so we find that this was the begining
of a problem which is not yet solved.
In July, 1938 Lian (36) reported his observations on
the results of the treatment of trachoma with sulfanilamide.
His series consisted of thirty patients and he found that
the conjunctival and corneal complications responded well.
However, he comes to the conclusion the sulfanilamide is
a valuable aid in combination with mechanical methods and
alone will not cure the disease.
In this country Dr. Fred Loe started to use sulfanilamide in trachoma at the same time Heinemann's report came
out but he did not publish his work until October, 1938 (38).
He states that in August, 193? he selected two patients,
one of whom had trachoma for two years the other eighteen
months, and treated them by giving one-third of a grain of
sulfanilamide per pound of body weight each day along with
an equivalent amount of sodium bicarbonate for the first
ten days. Then for the next fourteen days he gave them
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one-quarter of a grain of sulfanilamide per pound and an
equal amount of sodium bicarbonate. Five days after the
treatment was started he noticed that the redness of the
conjunctiva was disappearing, the granules and papules
were decreased in size and the blood vessels became increasingly visible. As a result of his treatment he states
that these two cases were apparently cured within one month.
On January 6, 1938 he started treating thirteen patients
sulfanilamide who had been under continuous treatment from
one to seven years. Three of these patients were dismissed
on Jan. 16, 1938 apparently cured, the other ten were greatly
improved after eight days of treatment and were given sulfanilamide for two weeks longer. At the meeting of the
American Medical Association in June, 1938 he reported the
results of 140 cases of trachoma, as previously mentioned,
and from the conclusions made it is assumed that all of the
cases were arrested.
In 1938, at the same time Loe presented his paper to
the American Medical Association, Gradle (18) read a report
on the treatment of a series of 41 patients with sulfanilamide in which 25 percent did not respond to treatment and
75 percent, although not stated, are supposed to have been
arrested. Even though his paper had been published before
Loe's, Gradle gives all priority to him.
Also in 1938 in Great Britian Kirk, McKelvie, and
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Hussien (33) proceeded to try out sulfanilamide. They
based their trial solely on some research work which had
shown the value of the drug in healing a meningitis induced in mice by the virus of Lymphogranuloma Inguinale
and which showed Rickettsia-like bodies similar to those
found in trachoma. They treated twenty-five patients using
22t grains of sulfanilamide daily in alternate seven day

courses. They noted that the greatest improvement was seen
where pannus and keratitis were present. From their results
they concluded that the permanent effectiveness of the
drug still had to be ascertained.
In a series of twenty-five patients, after two weeks
of treatment and observation, Hirschfelder (23) got the
impression that sulfanilamide has a paling and drying effect
on the conjunctiva of trachoma stage II and milder cases
of stage III. Also he noticed that it seemed to aid in the
healing of pannus in cases that are not too old and not too
malignant. He used the dosage and procedure recommended by
Loe and reached the conclusion that the question whether
or not the drug can completely arrest the disease or prevent recurrences is still not settled.
In April, 1939 Richards, Forster, and Thygeson (56)
published a report of the treatment of twelve Indian children by the method of Loe. All of these children showed active
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trachoma with follicular hypertrophy and pannus and all
showed striking improvement. At the end of four and a
half months the conjunctiva in each instance had become
follicle free and smooth. In every eye, except one, there
was a disappearance of corneal infiltrates and an apparent
arrest of corneal activity. Also in every case the drug
caused the disappearance of the epithelial cell inclusion
so characteristic of active trachorna so it is assumed
that all cases were arrested.
In August, 1939 a very interesting paper appeared in
the literature. Brav (4) treated one case of recurrent
trachornatous ulceration of the cornea with instillation
of a two and one-half percent solution of neoprontosil
locally. This ulceration cleared up and the pain was relieved by this procedure. This is the first instance of a
sulfanilamide derivative being used locally.
In October, 1939 at a staff meeting of the Mayo Clinic
Harley, Brown, and Herrell (21) made known their findings
of treating trachoma with sulfanilamide and it's derivatives.
In a series of eleven cases, four of which were treated with
neoprontosil because they were intolerant to sulfanilamide,
they found marked objective and subjective improvement in
each case. All cases were grouped as stage II or III according to MacCallan's classification. In regard to neoprontosil
they reached the conclusion that although the results were

34

not as dramatic they compare very favorably with those
secured with sulfanilamide.
The use of sulfapyridine in the treatment of trachoma
was reported for the first time by Spearman and Vandevere
(60) in November, 1939. Their series consisted of two cases
that had been intractable to all other methods, one with
sulfanilamide. They were greatly impressed with the remarkable remission of pathologic signs and the improvement of
vision secured.
In November, 1939 Julianelle, Lane, and Whitted (29)
published their results on a series of 113 patients, all
were Indians except for six white patients. They used the
dosage recommened by Loe and found that twenty percent recovered, forty percent showed varying degrees of improvement and forty percent were not improved. So they reached
the conclusion that the drug has marked and rapid effect
on the secondary infections commonly associated with trachoma
and that most striking results were seen in those patients
with exacerbative disease.
Wilson (?6) reported a series of eighteen patients
that recieved one-third grain of sulfanilamide per pound
of body weight each day for three weeks and then one-quarter
of a grain per pound each day for three weeks. He also used
a two percent ointment locally and secured an arrest of the
disease process in all cases.
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Lugossy (39) in a report published December, 1939
found that sulfanilamide preparations were of the greatest
value in those cases of trachoma. which were complicated by
pannus and corneal ulcers. However, he concludes that sulfanilamide itself does not cure trachoma but hastens the
curative effects of such remedies as injection of foreign
proteins.
Another large series consisting of 100 patients was
reported by

Sie-Boen~Lian

in December, 1939 (37). He re-

ached the conclusions that the drug was effective in reducing secretion and diffuse thickening, papillary thickening influenced but little, the granules were not affected,
and that the corneal complications (pannus, keratitis,
corneal ulcer) responded best of all. He also found that
recurrences of complications were rare.
In March, 1940 Spining (61) in Ganado, Arizona being
stimulated by Loe's report and using the dosage outlined by
him reports the treatment of fifteen adults with chronic
trachoma associated with other acute eye conditions, such
as bulbar conjunctivitis, phylycentular conjunctivitis, and
corneal ulcers. He found that all of them recovered rapidly
from the acute manifestations but in none of them could he
find any evidence that the underlying trachoma. was cured or
even greatly improved. He also reports that seventeen children between the ages of eight and fourteen years with chronic
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trachoma. and little or no bulbar or corneal involvement
other than slight pannus were treated with sulfanilamide
for periods of seven to twenty-four days. In only one of
these children was a clinical cure obtained, the other
sixteen showed only slight to moderate improvement.
MacCallan (41) of the British school in March, 1940
published a report after using sulfapyridine. The report
does not say how many cases were treated but the dosage
used was three grams the first day and two grams on each
succeeding day for nine days along with an equivalent
amount of sodium bicarbonate. He concludes that up to the
present time the drugs of the sulfonamide group have been
found to be without effect on any virus disease and consequently has no effect on trachoma., since it is of the
virus class. He believes that the good results obtained
in the treatment of trachoma. by these drugs have been procured by the elimination of superimposed bacterial infections.
The results secured in another large series was reported in :May, 1940 by Forster ( 14). He used sulfanilamide
in a dosage of one-half grain per pound of body weight daily,
divided into four doses, for twenty-one days then if there
was any evidence of trachoma.tous activity they were given
a second course identical with the first. The disease, in
125 out of 167 trachoma.tous children became clinically

37

arrested following the one course. In the rest, the disease became arrested following the second course. He found
that the effect of the drug on stage I was very striking,
the conjunctiva and cornea returning to normal in ten days,
but in the advanced cases the effect was slower.
Also in May, 1940 Kettler and Rutherford (32) reported
a series of 63 patients out of which eight eyes were blind,
one globe shrunken, and one enucleated. They used ten grains
of sulfanilamide three times daily the first week and then
ten grains twice a day for four to eight weeks and instilled
into the conjunctival sac one drop of a two and half percent
solution of neoprontosil four times daily. If the eyelid
deformities were bad the patient was hospitalized and surgical correction done and during the time of hospitalization
one-third grain per pound, maximum of forty grains, was given
orally. They found that out of the 116 eyes capable of being
improved the vision in 56 of them was improved. They concluded that improvement occurred in inverse proportion to
the number and severity of complications, that the acute
exacerbations of old trachoma with infective secretion are
quickly controlled, that you can cure practically all in
whom the infection has been recently acquired and where no
complications have developed.
Thygeson (69) in June, 1940 reported a series of 31
cases of trachoma treated with sulfanilamide. Of these 16
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were healed, 11 showed satisfactory improvement, and 4
exhibited little or no change. He concludes that his results confirm the claims of Loe and others that sulfanilamide exerts a definite curative effect in a high percentage of active trachoma cases. He also states that the effect
is primarily on the trachoma virus rather than on the secondary invaders because of the striking results obtained
in pure, uncomplicated cases and by the uniform disappearance of the epithelial cell inclusion bodies characteristic
of the active disease.
As a result of work done by them in China, Lee and
Rottenstein (34) reported a series of 95 cases in July, 1940.
Seventy-five of these patients were treated by giving a
daily dose of sulfanilamide of 0.02 gm. per pound of body
weight for two to four weeks. Twenty of these patients were
treated with sulfanilamide given intramuscularly in a dose
of two to five grams per injection. Sulfanilamide was given
every four days and sulfapyridine every seven to ten days,
with a total of two to six injections being all that was
necessary. They concluded that the treatment was effective
in stages I,II, and III and that the intramuscular route
was most effective.
In August, 1940 Hammond (20) reported a series of 12
cases of acute trachoma. that were treated by giving sulfanilamide in doses of forty grains per day for two weeks,
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thirty grains for three weeks, and twenty grains for two
to six months, depending on how often the patients returned
to have their prescriptions filled. He found that in every
case there was marked improvement or complete arrest.
Also in August, 1940 Cosgrove (8) reported a series of
107 cases treated with both oral and local sulfanilamide.
He reports that equal improvement of visual acuity was obtained by both methods individually and that the symptomatic relief of the patient with trachoma on local aulfanilamide is apparently as rapid and complete as that obtained from oral use. He also suggests that it may be possible
to prevent the recurrence of trachoma. after sulfanilamide
therapy by the continued local use of the drug.
In September, 1940 Cooper (?) reported some observations
which are entirely different from others and very interesting.
In a series of 34 patients with trachoma. treated with sulfanilamide, a recurrence of 62 percent was encountered within six to thirty months. Of those recurrences 16 were treated
subsequently with iontophoresis and none had a second recurrence, a majority of them being followed for over two
years. He suggests that routine treatment of trachoma consist
of at least eight applications of quinine bisulphate by
iontophoresis following apparent cure by sulfanilamide, as
a prophylactic measure against recurrence. However, he warns
that you cannot carry out iontophoresis until aulfanilamide
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therapy has been completed because of the danger of producing a harsh reaction in the ocular tissues.
The latest report available was published in Feb.,
1941 by Smith, Julianelle, and Gamet (59). In their series
of 26 patients they used the dosage recommended by Loe.
Their results show that two cases were arrested, 11 were
improved but still clinically active, and 13 remained in
a stationary clinical condition. In the final analysis
they admit that 50 percent of the patients treated profited
from the administration of sulfanilamide.
Summary of Reports Reviewed
Twenty-four reports on the observations of various
observers have been reviewed. Of these all but those of
Heinemann (19), Brav (4), Spearman and Vandevere (60),
and Lugossy (39) can be fairly judged as to the results
of treatment of trachoma by sulfanilamide and it's derivatives.
Although all observers agree that trachomatous
patients secure relief of objective and subjective symptoms, not all of them agree that the disease process is
arrested. Julianelle, Lane, and Whitted (29), Spining (61),
Cooper (7), Smith, Julianelle, and Gamet (59) had comparatively poor results but even at that I believe they had
a fair enough percentage of arrestment of the disease
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process to warrant the use of sulfanilamide in the future.
Julianelle, Lane, and Whitted (29) and MacCallan (41) using
sulfapyridine, believed that the good results they did
secure was due to the effect on secondary invaders and
MacCallan states it has no effect on trachoma.
All the observers not mentioned in the preceeding
section had very good results, especially when the disease
was of recent origin but in numerous instances long standing
cases were cleared and arrested. Thygeson (69), in direct
opposition to M:acCallan (41), states that the drug has a
direct effect on the virus and little effect on the secondary invaders.
Several observers have recommended that some other form
of treatment be used in conjunction with sulfanilamide
therapy, or that sulfanilamide or neoprontosil be used
locally alone or in conjunction with oral use of sulfanilamide. I,ian (37) believes that some form of mechanical
treatment should be used with sulfanilamide therapy; Brav (4)
secured excellent results in one case from local use of
neoprontosil; Wilson (76) using sulfanilamide locally and
and orally secured excellent results; Kettler and Rutherford (32) using neoprontosil locally with oral use of
sulfanilamide had excellent results; Cosgrove (8) secured
favorable results from the use of sulfanilamide both orally
and locally; Cooper (7) by using iontophoresis in the
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recurrent cases of trachoma following sulfanilamide
therary had excellent results.
It seems that dosage and treatment time are probably
the two most important factors in explaining the varying
response of trachoma to sulfanilam.ide. The importance of
adequate dosage is well shown in the two series reported
by Richards, Forster, and Thygeson (56) and by Forster (14)
in which almost uniform healing was obtained on a daily
dosage of one-half grain of sulfanilam.ide per pound of
body weight continued for three weeks or longer, however,
the toxic effects of the drug, especially in regard to the
hemopoetic system, must always be kept in mind.
Conclusions
The experience of innumerable observers in the treatment
of trachoma with various methods during the entire history of
the disease definitely shows that it is impossible to attain
complete recovery in all patients and complete lack of recurrence in all individuals. So in the final analysis I believe that sulfanilamide has made a most prominent place for
itself in the treatment of trachoma and that it will stand the
test of time much better than previous forms of treatment except possibly the use of escharotic agents. Also the few
reports that are available on the subject, indicate that the
use of sulfanilamide or one of it's derivatives locally in
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conjunction with oral therapy of sulfanilamide or some
other local treatment such as that suggested by Cooper
(7) may be bf definite value but the literature is not
sufficient enough to judge fairly.
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